This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.



Edited by

Edited by Mone Zaidi (Mount Sinai School of Medicine, New York, New York)


Published: January 2015

Volume 1335

A new series in Annals, MARROW presents cutting-edge manuscripts on basic, translational, and clinical bone and bone marrow biology and medicine.

Learn More

MARROW is a series of Annals of the New York Academy of Sciences. Each issue presents Original Research manuscripts on topics in basic, translational, and clinical bone and bone marrow biology and medicine, as well as related scholarly Reviews, Perspectives, Commentaries, Technical Reports, and Brief Communications.

The scope of MARROW includes regenerative biology, osteoimmunology, intercellular signaling, integrative physiology, hematopoietic malignancies, contribution of bone marrow to metastatic disease, translational models and therapeutic considerations of diseases of bone and bone marrow, developmental aspects of bone marrow and bone, and hematopoiesis.

The inaugural issue contains a Commentary questioning the link between bisphosphonate use and atypical fractures; two Perspective articles, one on the role of ectoenzymes in myeloma, the other on bone marrow as a metastatic site of neuroblastoma; four Review articles on (1) bone marrow stem cells, (2) the osteoblastic niche in the context of multiple myeloma, (3) Notch signaling in the malignant bone marrow microenvironment, and (4) the function and regulation of primary cilia in the skeleton; and two Original Articles presenting new research on (1) follicle stimulating hormone receptor in mesenchymal stem cell signaling of reproductive hormones and (2) CB1 cannabinoid receptor mediation of endochondral skeletal growth retardation by tetrahydrocannabinol.